Context-dependent functions of pattern recognition receptors in cancer

SM Man, BJ Jenkins - Nature Reviews Cancer, 2022 - nature.com
The immune system plays a critical role in shaping all facets of cancer, from the early
initiation stage through to metastatic disease and resistance to therapy. Our understanding …

NLRP3 inflammasome activation in cancer: a double-edged sword

S Hamarsheh, R Zeiser - Frontiers in immunology, 2020 - frontiersin.org
Inflammation is involved in tumor development and progression as well as antitumor
response to therapy. In the past decade, the crosstalk between inflammation, immunity, and …

[HTML][HTML] Palmitoylation prevents sustained inflammation by limiting NLRP3 inflammasome activation through chaperone-mediated autophagy

L Wang, J Cai, X Zhao, L Ma, P Zeng, L Zhou, Y Liu… - Molecular cell, 2023 - cell.com
As a key component of the inflammasome, NLRP3 is a critical intracellular danger sensor
emerging as an important clinical target in inflammatory diseases. However, little is known …

[HTML][HTML] Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy

K Shahzad, F Bock, W Dong, H Wang, S Kopf, S Kohli… - Kidney international, 2015 - Elsevier
Diabetic nephropathy is a growing health concern with characteristic sterile inflammation. As
the underlying mechanisms of this inflammation remain poorly defined, specific therapies …

Inflammasome signaling in colorectal cancer

BR Sharma, TD Kanneganti - Translational Research, 2023 - Elsevier
Colorectal cancer (CRC) is one of the leading causes of cancer-related deaths in the world.
Inflammation is often an underlying risk factor for developing CRC. Maintaining gut …

NOD-like receptors: master regulators of inflammation and cancer

M Saxena, G Yeretssian - Frontiers in immunology, 2014 - frontiersin.org
Cytosolic NOD-like receptors (NLRs) have been associated with human diseases including
infections, cancer, and autoimmune and inflammatory disorders. These innate immune …

NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients

S Malhotra, C Costa, H Eixarch, CW Keller, L Amman… - Brain, 2020 - academic.oup.com
Primary progressive multiple sclerosis is a poorly understood disease entity with no specific
prognostic biomarkers and scarce therapeutic options. We aimed to identify disease activity …

Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry

R Levy, L Gérard, J Kuemmerle-Deschner… - Annals of the …, 2015 - ard.bmj.com
Objective To evaluate genetic, demographic and clinical features in patients with cryopyrin-
associated periodic syndrome (CAPS) from the Eurofever Registry, with a focus on genotype …

Danger signalling during cancer cell death: origins, plasticity and regulation

AD Garg, S Martin, J Golab, P Agostinis - Cell Death & Differentiation, 2014 - nature.com
Accumulating data indicates that following anti-cancer treatments, cancer cell death can be
perceived as immunogenic or tolerogenic by the immune system. The former is made …

Implications of combined NOD2 and other gene mutations in autoinflammatory diseases

H Nomani, Z Deng, B Navetta-Modrov, J Yang… - Frontiers in …, 2023 - frontiersin.org
NOD-like receptors (NLRs) are intracellular sensors associated with systemic
autoinflammatory diseases (SAIDs). We investigated the largest monocentric cohort of …